September 29, 2025

BrightSpring Health Services, I (BTSG) Stock Analysis: A Strong Buy with 7.40% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a pivotal player in the healthcare sector, is attracting attention from investors due to its robust growth metrics and positive analyst sentiment. Operating within the..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a 71% Upside Potential with Innovative Diagnostics

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands out in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of $3.44 billion, Lantheus plays..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 50% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically in the medical devices industry, is capturing investor interest with its substantial potential upside. Headquartered in Billerica, Massachusetts,..

RadNet, Inc. (RDNT) Stock Analysis: Growth Potential in Diagnostic Imaging with a 4.45% Upside

RadNet, Inc. (NASDAQ: RDNT), a key player within the healthcare sector, specializes in providing outpatient diagnostic imaging services. The company operates through its Imaging Centers and Digital Health segments, offering..

Telix Pharmaceuticals Limited (TLX) Investor Outlook: A Biotech Gem with Over 110% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning biotech firm headquartered in North Melbourne, Australia, is making waves in the healthcare sector. With its focus on the development and commercialization of..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Innovator with 11.57% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative solutions and robust market presence...

Incyte Corporation (INCY) Stock Analysis: Navigating the Biotech Sector with a Promising Forward P/E of 11.54

Incyte Corporation (INCY), a key player in the biotechnology industry, has captured the attention of investors with its innovative therapeutics and robust performance metrics. Headquartered in Wilmington, Delaware, this biopharmaceutical..

Integer Holdings Corporation (ITGR): Investor Outlook with a Promising 38.79% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its robust growth potential and strategic positioning in the..

Tempus AI, Inc. (TEM) Stock Analysis: Impressive Revenue Growth Amid Challenging Valuation Metrics

Tempus AI, Inc. (NASDAQ: TEM) stands as a compelling player in the healthcare technology sector, operating at the intersection of advanced diagnostics and data analytics. Founded in 2015 and headquartered..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Leader with 18.5% Revenue Growth and Attractive Analyst Ratings

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $9.95 billion, it..

GE HealthCare Technologies Inc. (GEHC) Investor Outlook: Unlocking a 21% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) is making waves in the healthcare sector with its robust portfolio and strategic focus on advanced medical technologies. With a market capitalization of $33.08..

Prestige Consumer Healthcare (PBH) Stock Analysis: 31.49% Potential Upside Sparks Investor Interest

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a notable player in the healthcare sector, specializing in over-the-counter (OTC) health and personal care products. With a market capitalization of $3.1 billion,..

Humana Inc. (HUM) Stock Analysis: Is the 17% Potential Upside Worth Your Investment?

Humana Inc. (NYSE: HUM) stands as a significant player in the healthcare sector, specializing in healthcare plans. With its headquarters in Louisville, Kentucky, Humana has established itself as a formidable..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Investor Ratings Indicate Promising Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is capturing investor attention in the biotechnology sector, with recent analyst ratings reflecting a solid upside potential for this commercial-stage company. Positioned at the forefront..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings and 26.76% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY) operates at the intersection of healthcare and technology, offering a suite of services designed to streamline financial management for health-related expenses. With a market capitalization of..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with a 10.53% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands as a prominent entity in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $5.3 billion, Teleflex’s..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the U.S. healthcare technology sector, has been making waves with its innovative approach to health insurance and technology-driven healthcare solutions. With..

DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.35% Upside in the Healthcare Sector

Investors looking to capture value in the healthcare sector might want to consider DaVita Inc. (NYSE: DVA), a key player in the medical care facilities industry, with a market capitalization..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant’s Potential Upside and Investment Appeal

McKesson Corporation (NYSE: MCK) stands tall in the healthcare sector as a prominent player in medical distribution, providing vital services across the United States and globally. With a market cap..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: An Exciting 61.92% Upside Potential for Biotech Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO) is making waves in the biotechnology sector with its innovative approach to addressing serious metabolic diseases. With a market capitalization of $3.82 billion and a..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds